Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berenbaum

Showing results (761-770 of 805) with videos related to

Pageof 81
Sort By:
Annals of the Rheumatic Diseases|May 30, 2014
Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA)Maxime Dougados, Martin Soubrier, Elodie Perrodeau, et al.
Ageing Research Reviews|August 23, 2019
Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)Emmanuel Biver, Francis Berenbaum, Ana M Valdes, et al.
Rheumatology Advances in Practice|April 8, 2022
The impact of COVID-19 on rheumatology training-results from the COVID-19 Global Rheumatology Alliance trainee surveyKristen Young, Su-Ann Yeoh, Michael Putman, et al.
Osteoarthritis Imaging|June 4, 2026
Impact of quantified knee positioning on the measurement of minimal joint space width using statistical shape models: A cross-sectional and longitudinal analysis in the IMI-APPROACHEva A Bax, H Chien Nguyen, Roel J H Custers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2019
A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With SynovitisRoy M Fleischmann, Henning Bliddal, Francisco J Blanco, et al.
Joint Bone Spine|September 15, 2020
Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritisJérémie Sellam, Alice Courties, Florent Eymard, et al.
BMC Musculoskeletal Disorders|November 18, 2022
Structural tissue damage and 24-month progression of semi-quantitative MRI biomarkers of knee osteoarthritis in the IMI-APPROACH cohortFrank W Roemer, Mylène Jansen, Anne C A Marijnissen, et al.
Osteoarthritis and Cartilage|November 10, 2024
Longitudinal stability of molecular endotypes of knee osteoarthritis patientsMonica T Hannani, Christian S Thudium, Alfred C Gellhorn, et al.
Rheumatology (Oxford, England)|May 16, 2022
Predicted and actual 2-year structural and pain progression in the IMI-APPROACH knee osteoarthritis cohortEefje M van Helvoort, Mylène P Jansen, Anne C A Marijnissen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 18, 2022
A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung DiseasePierre-Antoine Juge, Benjamin Granger, Marie-Pierre Debray, et al.
Pageof 81

Showing results (761-770 of 805) with videos related to

Sort By:
Pageof 81
Annals of the Rheumatic Diseases|May 30, 2014
Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA)Maxime Dougados, Martin Soubrier, Elodie Perrodeau, et al.
Ageing Research Reviews|August 23, 2019
Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)Emmanuel Biver, Francis Berenbaum, Ana M Valdes, et al.
Rheumatology Advances in Practice|April 8, 2022
The impact of COVID-19 on rheumatology training-results from the COVID-19 Global Rheumatology Alliance trainee surveyKristen Young, Su-Ann Yeoh, Michael Putman, et al.
Osteoarthritis Imaging|June 4, 2026
Impact of quantified knee positioning on the measurement of minimal joint space width using statistical shape models: A cross-sectional and longitudinal analysis in the IMI-APPROACHEva A Bax, H Chien Nguyen, Roel J H Custers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2019
A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With SynovitisRoy M Fleischmann, Henning Bliddal, Francisco J Blanco, et al.
Joint Bone Spine|September 15, 2020
Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritisJérémie Sellam, Alice Courties, Florent Eymard, et al.
BMC Musculoskeletal Disorders|November 18, 2022
Structural tissue damage and 24-month progression of semi-quantitative MRI biomarkers of knee osteoarthritis in the IMI-APPROACH cohortFrank W Roemer, Mylène Jansen, Anne C A Marijnissen, et al.
Osteoarthritis and Cartilage|November 10, 2024
Longitudinal stability of molecular endotypes of knee osteoarthritis patientsMonica T Hannani, Christian S Thudium, Alfred C Gellhorn, et al.
Rheumatology (Oxford, England)|May 16, 2022
Predicted and actual 2-year structural and pain progression in the IMI-APPROACH knee osteoarthritis cohortEefje M van Helvoort, Mylène P Jansen, Anne C A Marijnissen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 18, 2022
A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung DiseasePierre-Antoine Juge, Benjamin Granger, Marie-Pierre Debray, et al.
Pageof 81